Comparison of ultrasonography and uroflowmetry in diagnosis of bladder outlet obstruction due to benign prostatic hyperplasia

Comparison of ultrasonography and uroflowmetry index in diagnosis of bladder outlet obstruction in patients with lower urinary tract symptom due to benign prostatic hyperplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016022326718N1

Enrollment

250

Registered

2016-05-11

Start date

2015-08-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder outlet obstruction. Bladder-neck obstruction

Interventions

Intervention 1: Abdominal ultrasonography. Intervention 2: Uroflowmetery.

Diagnosis

Abdominal ultrasonography

Uroflowmetery

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients peresenting with lower urinary tract symptom (LUTS) due to benign prostate hyperplasia (BPH) Exclusion criteria: history of prostatitis; urinary tract surgery; trauma; Urethritis; urinary stone passage; Catheterization; abnormal prostate specific antigene (PSA) and digital rectal exam (DRE); BPH surgical criterias; Neurogenic bladder

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Prostate volume. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Urine residue. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Bladder wall thickness. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Intravesical protrusion of prostate. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Qmax. Timepoint: During hospitalization. Method of measurement: Uroflowmetery.;International Prostate Symptom Score. Timepoint: During hospitalization. Method of measurement: Based on a standard questionnaire with scores of 0 to 35.;Prostate specific antigen. Timepoint: During hospitalization. Method of measurement: Blood test.	—

Measure

Time frame

Prostate volume. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Urine residue. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Bladder wall thickness. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Intravesical protrusion of prostate. Timepoint: During hospitalization. Method of measurement: Ultrasonography.;Qmax. Timepoint: During hospitalization. Method of measurement: Uroflowmetery.;International Prostate Symptom Score. Timepoint: During hospitalization. Method of measurement: Based on a standard questionnaire with scores of 0 to 35.;Prostate specific antigen. Timepoint: During hospitalization. Method of measurement: Blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sahand Omidi

Urology Research Center

urc1384@yahoo.com+98 13 3352 5259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026